N Engl J Med 383:14251435 McMurray JJV, Solomon SD, Inzucchi SE, Kber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Blohlvek J, Bhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukt A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, OMeara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjstrand M, Langkilde AM (2019) DAPA-HF Trial Committees and Investigators
For example GLP-1s are being studied for treatment of other illnesses, like cardiovascular disease, heart failure, liver disorders, and obstructive sleep apnea
cardiovascular disease
Ive lost 48 pounds in a year, my A1c levels have dropped to a healthy range, and my primary care physician took me off my diabetes medication and commended me on my weight loss journey